XML 392 R53.htm IDEA: XBRL DOCUMENT v3.25.1
Performance B.4.1. Share-based compensation - Plan awards and shares expected to vest (Details)
$ in Millions
12 Months Ended
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
shares
Dec. 31, 2022
shares
Dec. 31, 2021
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Shares issued (in shares) (270,850) (719,642)    
Shares still expected to vest (in shares) 474,225 1,573,187    
2024 Performance Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 695,936      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) 0      
Shares cancelled in 2024 (in shares) (438,396)      
Total before issuances (in shares) 257,540      
Shares issued (in shares) 0 0 0 0
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 257,540      
Estimated cost over the vesting period | $ $ 7      
2024 Performance Plan | Share Appreciation Rights Units (SARs)        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Shares still expected to vest (in shares) 186,409      
2024 Deferred Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 1,139,838      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) (45,121)      
Shares cancelled in 2024 (in shares) (229,963)      
Total before issuances (in shares) 864,754      
Shares issued (in shares) (135,092) 0 0 0
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 729,662      
Estimated cost over the vesting period | $ $ 21      
2023 Performance Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 818,842      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) (233,398)      
Shares cancelled in 2024 (in shares) (308,172)      
Total before issuances (in shares) 277,272      
Shares issued (in shares) (66,519) (31,124) 0 0
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 179,629      
Estimated cost over the vesting period | $ $ 15      
2023 Deferred Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 2,375,143      
Number of shares for rights offering, in share-based payment arrangement (in shares) 0      
Revision for forfeitures (in shares) (143,340)      
Shares cancelled in 2024 (in shares) (244,537)      
Total before issuances (in shares) 1,987,266      
Shares issued (in shares) (824,237) (354,331) 0 0
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 808,698      
Estimated cost over the vesting period | $ $ 42      
2022 Performance Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 306,641      
Number of shares for rights offering, in share-based payment arrangement (in shares) 83,926      
Revision for forfeitures (in shares) (68,520)      
Shares cancelled in 2024 (in shares) (144,108)      
Total before issuances (in shares) 177,939      
Shares issued (in shares) (49,245) (29,885) 0 0
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 98,809      
Estimated cost over the vesting period | $ $ 9      
2022 Deferred Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 913,450      
Number of shares for rights offering, in share-based payment arrangement (in shares) 227,947      
Revision for forfeitures (in shares) (83,910)      
Shares cancelled in 2024 (in shares) (33,305)      
Total before issuances (in shares) 1,024,182      
Shares issued (in shares) (312,725) (476,256) (13,957) 0
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 221,244      
Estimated cost over the vesting period | $ $ 21      
2021 Performance Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 451,363      
Number of shares for rights offering, in share-based payment arrangement (in shares) 115,575      
Revision for forfeitures (in shares) (63,796)      
Shares cancelled in 2024 (in shares) 0      
Total before issuances (in shares) 503,142      
Shares issued (in shares) (352,286) (120,419) (2,071) (1,121)
Performance conditions not met (in shares) (27,245)      
Shares still expected to vest (in shares) 0      
Estimated cost over the vesting period | $ $ 0      
2021 Deferred Plan        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Initial shares granted (in shares) 542,714      
Number of shares for rights offering, in share-based payment arrangement (in shares) 93,375      
Revision for forfeitures (in shares) (46,358)      
Shares cancelled in 2024 (in shares) 0      
Total before issuances (in shares) 589,731      
Shares issued (in shares) (189,218) (234,157) (160,596) (5,760)
Performance conditions not met (in shares) 0      
Shares still expected to vest (in shares) 0      
Estimated cost over the vesting period | $ $ 0